Mesenchymal Stromal Cells; a New Horizon in Regenerative Medicine Publisher Pubmed



Tavakoli S^{1, 3} ; Ghaderi Jafarbeigloo HR² ; Shariati A³ ; Jahangiryan A⁴ ; Jadidi F⁵ ; Jadidi Kouhbanani MA⁶ ; Hassanzadeh A³ ; Zamani M⁷ ; Javidi K⁸ ; Naimi A⁹
Source: Journal of Cellular Physiology Published:2020

Abstract

In recent decades, mesenchymal stromal cells (MSCs) biomedical utilizing has attracted worldwide growing attention. After the first report of the human MSCs obtaining from the bone marrow (BM) tissue, these cells were isolated from wide types of the other tissues, ranging from adipose tissue to dental pulp. Their specific characteristics, comprising self-renewality, multipotency, and availability accompanied by their immunomodulatory properties and little ethical concern denote their importance in the context of regenerative medicine. Considering preclinical studies, MSCs can modify immune reactions during tissue repair and restoration, providing suitable milieu for tissue recovery; on the other hand, they can be differentiated into comprehensive types of the body cells, such as osteoblast, chondrocyte, hepatocyte, cardiomyocyte, fibroblast, and neural cells. Though a large number of studies have investigated MSCs capacities in regenerative medicine in varied animal models, the oncogenic capability of unregulated MSCs differentiation must be more assessed to enable their application in the clinic. In the current review, we provide a brief overview of MSCs sources, isolation, and expansion as well as immunomodulatory activities. More important, we try to collect and discuss recent preclinical and clinical research and evaluate current challenges in the context of the MSC-based cell therapy for regenerative medicine. © 2020 Wiley Periodicals LLC